ZUG, Switzerland, May 3, 2023 - MoonLake Immunotherapeutics (NASDAQ: MLTX) ("MoonLake"), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, today
/PRNewswire/ SHL Medical, a world-leading provider of advanced drug delivery solutions, announced that it has signed a collaboration agreement with MoonLake.
MoonLake Immunotherapeutics (MLTX) and SHL Medical Partner to Develop an Autoinjector for sonelokimab Supply streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
MoonLake Immunotherapeutics signs development and manufacturing agreement with Vetter Pharma International GmbH ZUG, Switzerland, July 26, 2022 - MoonLake Immunotherapeutics AG (MoonLake; Nasdaq: MLTX)
Investegate announcements from MoonLake Immunotherapeutics AG, MoonLake Immunotherapeutics signs development and manufacturing agreement with Vetter Pharma International GmbH